Cumberland first to unbolt IPO window
This article was originally published in Scrip
Executive Summary
Cumberland Pharmaceuticals has become the first life science company to brave the IPO waters for 18 months and the first purely pharmaceutical company to do so in nearly two years in an attempt to raise $85 million.